BioCentury
ARTICLE | Financial News

Celsus Therapeutics proposes follow-on

December 23, 2013 8:00 AM UTC

Celsus Therapeutics plc (OTCQB: CLSXY), London, U.K. Business: Inflammation Date announced: 12/11/13 Type: Follow-on To be raised: Up to $11.5 million Shares: TBD Price prior: $1.50 Underwriter: Oppen...